SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression
Abstract Background Gastric cancer (GC) continues to pose a significant global health burden, necessitating a thorough understanding of the molecular mechanisms driving its progression. This study aimed to investigate the regulatory role of SMAD3 in modulating Sestrin2 ubiquitination stability and i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Cell Division |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13008-025-00163-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763964163981312 |
|---|---|
| author | Ning Zhang Na Zhao Hainan Zhang Le Yao Hongtao Si |
| author_facet | Ning Zhang Na Zhao Hainan Zhang Le Yao Hongtao Si |
| author_sort | Ning Zhang |
| collection | DOAJ |
| description | Abstract Background Gastric cancer (GC) continues to pose a significant global health burden, necessitating a thorough understanding of the molecular mechanisms driving its progression. This study aimed to investigate the regulatory role of SMAD3 in modulating Sestrin2 ubiquitination stability and its implications in GC cell behaviors. Methods Leveraging GC-related single-cell transcriptomic data, we employed advanced analytical approaches to unveil the relationship between SMAD3 and Sestrin2. Experimental validations involving RT-qPCR, Western blotting, and immunofluorescence analyses elucidated the impact of SMAD3 on Sestrin2 expression and subcellular localization. In vitro models of SMAD3 overexpression and knockdown were utilized to assess the functional consequences on GC cell proliferation, migration, invasion, and apoptosis. The interaction between SMAD3 and ubiquitination-related enzymes RNF167 and STAMBPL1 was investigated through immunoprecipitation assays. Results Our findings revealed a positive correlation between SMAD3, Sestrin2, and STAMBPL1 expression, indicating a regulatory network within GC cells. SMAD3 was shown to stabilize Sestrin2 protein levels by influencing the ubiquitination processes of STAMBPL1 and RNF167. Functional assays demonstrated the promotion of GC cell proliferation, migration, and invasion, along with decreased apoptosis, by the SMAD3-Sestrin2 axis. Moreover, SMAD3-mediated regulation of Sestrin2 stability was found to enhance GC metastasis. Conclusion The study underscores the critical role of SMAD3 in modulating Sestrin2 expression and stability, consequently impacting GC cell behaviors and metastatic potential. The SMAD3-Sestrin2 axis emerges as a promising therapeutic target for GC treatment. Graphic abstract Multimodal analysis reveals the molecular mechanism by which SMAD3 mediates the synergistic regulation of Sestrin2’s polyubiquitination levels through RNF167 and STAMBPL1 to induce GC. |
| format | Article |
| id | doaj-art-924c3a75e3274d52a7c6cdf32a1d92ff |
| institution | DOAJ |
| issn | 1747-1028 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Cell Division |
| spelling | doaj-art-924c3a75e3274d52a7c6cdf32a1d92ff2025-08-20T03:05:15ZengBMCCell Division1747-10282025-08-0120111510.1186/s13008-025-00163-zSMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progressionNing Zhang0Na Zhao1Hainan Zhang2Le Yao3Hongtao Si4Department of Gastroenterology, The Second Hospital of Hebei Medical UniversityDepartment of Gastroenterology, The Second Hospital of Hebei Medical UniversityDepartment of Internal Medicine, Anxin County HospitalDepartment of Gastroenterology, The Second Hospital of Hebei Medical UniversityDepartment of General Surgery IV, The Second Hospital of Hebei Medical UniversityAbstract Background Gastric cancer (GC) continues to pose a significant global health burden, necessitating a thorough understanding of the molecular mechanisms driving its progression. This study aimed to investigate the regulatory role of SMAD3 in modulating Sestrin2 ubiquitination stability and its implications in GC cell behaviors. Methods Leveraging GC-related single-cell transcriptomic data, we employed advanced analytical approaches to unveil the relationship between SMAD3 and Sestrin2. Experimental validations involving RT-qPCR, Western blotting, and immunofluorescence analyses elucidated the impact of SMAD3 on Sestrin2 expression and subcellular localization. In vitro models of SMAD3 overexpression and knockdown were utilized to assess the functional consequences on GC cell proliferation, migration, invasion, and apoptosis. The interaction between SMAD3 and ubiquitination-related enzymes RNF167 and STAMBPL1 was investigated through immunoprecipitation assays. Results Our findings revealed a positive correlation between SMAD3, Sestrin2, and STAMBPL1 expression, indicating a regulatory network within GC cells. SMAD3 was shown to stabilize Sestrin2 protein levels by influencing the ubiquitination processes of STAMBPL1 and RNF167. Functional assays demonstrated the promotion of GC cell proliferation, migration, and invasion, along with decreased apoptosis, by the SMAD3-Sestrin2 axis. Moreover, SMAD3-mediated regulation of Sestrin2 stability was found to enhance GC metastasis. Conclusion The study underscores the critical role of SMAD3 in modulating Sestrin2 expression and stability, consequently impacting GC cell behaviors and metastatic potential. The SMAD3-Sestrin2 axis emerges as a promising therapeutic target for GC treatment. Graphic abstract Multimodal analysis reveals the molecular mechanism by which SMAD3 mediates the synergistic regulation of Sestrin2’s polyubiquitination levels through RNF167 and STAMBPL1 to induce GC.https://doi.org/10.1186/s13008-025-00163-zSMAD family member 3Sestrin2UbiquitinationGastric CancerCell proliferation |
| spellingShingle | Ning Zhang Na Zhao Hainan Zhang Le Yao Hongtao Si SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression Cell Division SMAD family member 3 Sestrin2 Ubiquitination Gastric Cancer Cell proliferation |
| title | SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression |
| title_full | SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression |
| title_fullStr | SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression |
| title_full_unstemmed | SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression |
| title_short | SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression |
| title_sort | smad3 orchestrates rnf167 and stambpl1 mediated sestrin2 ubiquitination to drive gastric cancer progression |
| topic | SMAD family member 3 Sestrin2 Ubiquitination Gastric Cancer Cell proliferation |
| url | https://doi.org/10.1186/s13008-025-00163-z |
| work_keys_str_mv | AT ningzhang smad3orchestratesrnf167andstambpl1mediatedsestrin2ubiquitinationtodrivegastriccancerprogression AT nazhao smad3orchestratesrnf167andstambpl1mediatedsestrin2ubiquitinationtodrivegastriccancerprogression AT hainanzhang smad3orchestratesrnf167andstambpl1mediatedsestrin2ubiquitinationtodrivegastriccancerprogression AT leyao smad3orchestratesrnf167andstambpl1mediatedsestrin2ubiquitinationtodrivegastriccancerprogression AT hongtaosi smad3orchestratesrnf167andstambpl1mediatedsestrin2ubiquitinationtodrivegastriccancerprogression |